Doctors Welcome New Depression Drug, Cautiously

Doctors welcomed federal approval this week of a new, fast-acting nasal spray for depression. But also they expressed concerns about its cost and long-term effects, as well as the logistics of administering it in accordance with safety requirements. The new drug, esketamine, made by Janssen Pharmaceuticals, won approval from the Food and Drug Administration on…